|Podcasts|August 19, 2021
Episode 89: Cellicon Valley Outlook
Author(s)Elaine Quilici, Miranda Schmalfuhs
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.
Advertisement
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
3
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
4
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
5